State Bank of India posts a 10% rise in Q2 net profit to Rs 20,160 crore, driven by gains from its Yes Bank stake sale, while ...

Genetix Biotherapeutics Inc. today announced that an analysis of recent patient experience data from the commercial implementation of LYFGENIAtm and ZYNTEGLOtm in the U.S. has been selected for oral ...

INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...

It’s the height of meeting season! All our most-read stories this month hailed from the news team’s on-site coverage.